Rhythm Pharmaceuticals In...

NASDAQ: RYTM · Real-Time Price · USD
97.69
1.21 (1.25%)
At close: Aug 15, 2025, 3:59 PM
97.50
-0.19%
After-hours: Aug 15, 2025, 06:27 PM EDT

Rhythm Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
130.13M 77.43M 23.64M 3.15M
Cost of Revenue
13.37M 9.3M 2.13M 599K
Gross Profit
116.76M 68.13M 21.5M 2.56M
Operating Income
-265.5M -184.36M -179.16M -170.06M
Interest Income
14.71M 13.95M 4.03M 447K
Pretax Income
-260.26M -184.11M -181.12M -69.61M
Net Income
-260.6M -184.68M -183.08M -68.01M
Selling & General & Admin
144.3M 117.53M 92.03M 68.49M
Research & Development
237.96M 134.95M 108.63M 104.13M
Other Expenses
n/a n/a -790K n/a
Operating Expenses
382.26M 252.48M 200.66M 172.61M
Interest Expense
20.6M 13.89M 5.2M n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
395.63M 261.79M 202.79M 173.21M
Income Tax Expense
346K 564K 1.96M -1.6M
Shares Outstanding (Basic)
60.99M 57.67M 52.12M 49.6M
Shares Outstanding (Diluted)
60.99M 57.67M 52.12M 49.6M
EPS (Basic)
-4.21 -3.2 -3.51 -1.37
EPS (Diluted)
-4.21 -3.2 -3.51 -1.37
EBITDA
-238.09M -168.46M -174.51M -68.45M
EBIT
-239.65M -170.22M -175.92M -69.61M
Depreciation & Amortization
1.56M 1.76M 1.4M 1.16M